Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

dRx Capital

Investor type Micro VC

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 21
Average round size
info
The average size of a deal this fund participated in
$28M
Portfolio companies 13
Rounds per year 3.00
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits 2
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Medical Device
Summary

dRx Capital is the famous VC, which was founded in 2015. The main office of represented VC is situated in the San Diego. The company was established in North America in United States.

The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The average startup value when the investment from dRx Capital is 100-500 millions dollars. The important activity for fund was in 2016.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular fund investment industries, there are Information Technology, Neuroscience. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Omada Health, Cala Health, Science 37.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the dRx Capital, startups are often financed by Lux Capital, U.S. Venture Partners (USVP), TriplePoint Capital. The meaningful sponsors for the fund in investment in the same round are Lux Capital, GV, Sanofi-Genzyme BioVentures. In the next rounds fund is usually obtained by Sanofi-Genzyme BioVentures, Lux Capital, U.S. Venture Partners (USVP).

We also calculated 1 valuable employee in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of dRx Capital:
Typical Co-investors
dRx Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after dRx Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
DERTOUR Frankfurt, Germany, Hessen
IAN Fund Illinois, United States, Vermont
Lanx Capital Brazil, São Paulo, Sao Paulo
Leawood Venture Capital Kansas, Leawood, United States
Nexus Investment Canada, Ontario, Toronto
Reicon Capital Atlanta, Georgia, United States
Russell Investments Seattle, United States, Washington
Servisen Investment Management Stockholm, Stockholm County, Sweden
TMT Connekt Dubai, United Arab Emirates
Yijin Capital China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Peptone

Artificial Intelligence
Biotechnology
Pharmaceutical
Quantum Computing
$40M09 Jun 2022 London, England, United Kingdom

Koneksa Health

Analytics
Big Data
Health Care
$45M07 Feb 2022 New York, New York, United States

H1

Biotechnology
Health Care
Medical Device
Pharmaceutical
$121M16 Nov 2021 New York, New York, United States

Flywheel.io

Analytics
Cloud Data Services
Cloud Management
Software
$22M15 Sep 2021 Minneapolis, Minnesota, United States

Dopavision

Biotechnology
Health Care
Medical Device
Therapeutics
$14M14 Jul 2021 Berlin, Berlin, Germany

NuvoAir

Health Care
Medical
$12M22 Jun 2021 Boston, Massachusetts, United States

Flywheel.io

Analytics
Cloud Data Services
Cloud Management
Software
$15M03 Feb 2021 Minneapolis, Minnesota, United States

Peptone

Artificial Intelligence
Biotechnology
Pharmaceutical
Quantum Computing
$2M08 Jan 2021 England

H1

Biotechnology
Health Care
Medical Device
Pharmaceutical
$58M17 Dec 2020 New York, New York, United States
News
Inspired by founder’s childhood asthma, NuvoAir raises $12M to tackle respiratory illnesses

– NuvoAir, a Boston-based startup, raised $12m in Series A funding.
– The round was led by AlbionVC and joined by KAYA, Amino Collective and existing shareholders Spiltan, Industrifonden and dRx Capital.
– The company offers a combination of a Bluetooth-enabled spirometer that remotely monitors lung function; a sensor that attaches to asthma and COPD inhalers; and an integration with Fitbit devices.
– It also includes data from NuvoAir Cough, which assesses changes in nighttime coughing.
– Its business model is enabling health plans, insurance companies and healthcare systems to reduce the cost of managing their most severe respiratory patients, and also managing the care they provide.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent dRx Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: